Case report: A relatively rare adverse event caused by carbetocin- placenta interception.

Front Pharmacol

Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.

Published: March 2023

Placenta interception is extremely rare, and herein, we report the case of a 33-year-old woman with placenta interception during cesarean section caused by carbetocin, which was intravenously injected immediately after delivery of the infant to prevent postpartum hemorrhage. There was no sign of placental separation in the third stage of labor. A protuberance with gross subserous blood vessels in the left fundus of the uterus was detected and was misdiagnosed as placental accreta. The patient was transferred to the district referral hospital to manage the protuberance after stitching up the incision. On opening the original incision in the tertiary hospital, the protuberance disappeared, and the placenta was found in the lower segment of the uterus cavity. The intercepted placenta showed a spontaneous resolution from the uterine wall and was removed intact. This case report details the typical presentation of placenta interception to make obstetricians aware of the possibility that carbetocin might lead to this adverse event.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076695PMC
http://dx.doi.org/10.3389/fphar.2023.1112694DOI Listing

Publication Analysis

Top Keywords

placenta interception
16
case report
8
adverse event
8
placenta
6
report rare
4
rare adverse
4
event caused
4
caused carbetocin-
4
carbetocin- placenta
4
interception
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!